|
1
|
Lord AM, North TE and Zon LI:
Prostaglandin E2: Making more of your marrow. Cell Cycle.
6:3054–3057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ratajczak MZ and Suszynska M: Emerging
strategies to enhance homing and engraftment of hematopoietic stem
cells. Stem Cell Rev. 12:121–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharma M, Afrin F, Tripathi RP and
Gangenahalli G: Transgene expression study of CXCR4 active mutants.
Potential prospects in up-modulation of homing and engraftment
efficiency of hematopoietic stem/progenitor cells. Cell Adh Migr.
8:384–388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peled A, Petit I, Kollet O, Magid M,
Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz L, et al:
Dependence of human stem cell engraftment and repopulation of
NOD/SCID mice on CXCR4. Science. 283:845–848. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bao L and Huang XJ: SDF-1/CXCR4 and
multiple myeloma osteolytic bone lesions-review. Zhongguo Shi Yan
Xue Ye Xue Za Zhi. 16:442–446. 2008.(In Chinese). PubMed/NCBI
|
|
6
|
Okada K, Kawao N, Yano M, Tamura Y,
Kurashimo S, Okumoto K, Kojima K and Kaji H: Stromal cell-derived
factor-1 mediates changes of bone marrow stem cells during bone
repair process. Am J Physiol Endocrinol Metab. 310:E15–E23.
2016.PubMed/NCBI
|
|
7
|
Miller SB: Prostaglandins in health and
disease: An overview. Semin Arthritis Rheum. 36:37–49. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wiemer AJ, Hegde S, Gumperz JE and
Huttenlocher A: A live imaging cell motility screen identifies
prostaglandin E2 as a T cell stop signal antagonist. J Immunol.
187:3663–3670. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsutsumi R, Xie C, Wei X, Zhang M, Zhang
X, Flick LM, Schwarz EM and O'Keefe RJ: PGE2 signaling through the
EP4 receptor on fibroblasts upregulates RANKL and stimulates
osteolysis. J Bone Miner Res. 24:1753–1762. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fehér I and Gidáli J: Prostaglandin E2 as
stimulator of haemopoietic stem cell proliferation. Nature.
247:550–551. 1974. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
North TE, Goessling W, Walkley CR,
Lengerke C, Kopani KR, Lord AM, Weber GJ, Bowman TV, Jang IH,
Grosser T, et al: Prostaglandin E2 regulates vertebrate
haematopoietic stem cell homeostasis. Nature. 447:1007–1011. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pelus LM and Hoggatt J: Pleiotropic
effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and
other eicosanoids regulate hematopoietic stem and progenitor cell
function. Prostaglandins Other Lipid Mediat. 96:3–9. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hoggatt J, Singh P, Sampath J and Pelus
LM: Prostaglandin E2 enhances hematopoietic stem cell homing,
survival, and proliferation. Blood. 113:5444–5455. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sugimoto Y and Narumiya S: Prostaglandin E
receptors. J Biol Chem. 282:11613–11617. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kawamori T, Uchiya N, Nakatsugi S,
Watanabe K, Ohuchida S, Yamamoto H, Maruyama T, Kondo K, Sugimura T
and Wakabayashi K: Chemopreventive effects of ONO-8711, a selective
prostaglandin E receptor EP(1), on breast cancer development.
Carcinogenesis. 22:2001–2004. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawamori T, Uchiya N, Kitamura T, Ohuchida
S, Yamamoto H, Maruyama T, Sugimura T and Wakabayashi K: Evaluation
of a selective prostaglandin E receptor EP1 antagonist for
potential properties in colon carcinogenesis. Anticancer Res.
21:3865–3869. 2001.PubMed/NCBI
|
|
17
|
Yanochko GM, Affolter T, Eighmy JJ, Evans
MG, Khoh-Reiter S, Lee D, Miller PE, Shiue MH, Trajkovic D and
Jessen BA: Investigation of ocular events associated with
taprenepag isopropyl, a topical EP2 agonist in development for
treatment of glaucoma. J Ocul Pharmacol Ther. 30:429–439. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Birrell MA, Maher SA, Dekkak B, Jones V,
Wong S, Brook P and Belvisi MG: Anti-inflammatory effects of PGE2
in the lung: Role of the EP4 receptor subtype. Thorax. 70:740–747.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Logan CM, Giordano A, Puca A and Cassone
M: Prostaglandin E2: At the crossroads between stem cell
development, inflammation and cancer. Cancer Biol Ther.
6:1517–1520. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hoggatt J and Pelus LM: Eicosanoid
regulation of hematopoiesis and hematopoietic stem and progenitor
trafficking. Leukemia. 24:1993–2002. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gori JL, Chandrasekaran D, Kowalski JP,
Adair JE, Beard BC, D'Souza SL and Kiem HP: Efficient generation,
purification, and expansion of CD34(+) hematopoietic progenitor
cells from nonhuman primate-induced pluripotent stem cells. Blood.
120:e35–e44. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goessling W, Allen RS, Guan X, Jin P,
Uchida N, Dovey M, Harris JM, Metzger ME, Bonifacino AC, Stroncek
D, et al: Prostaglandin E2 enhances human cord blood stem cell
xenotransplants and shows long-term safety in preclinical nonhuman
primate transplant models. Cell Stem Cell. 8:445–458. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Durand EM and Zon LI: Newly emerging roles
for prostaglandin E2 regulation of hematopoiesis and hematopoietic
stem cell engraftment. Curr Opin Hematol. 17:308–312. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Inman MD, Denburg JA, Ellis R, Dahlbäck M
and O'Byrne PM: The effect of treatment with budesonide or PGE2 in
vitro on allergen-induced increases in canine bone marrow
progenitors. Am J Respir Cell Mol Biol. 17:634–641. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ruan D and So SP: Prostaglandin E2
produced by inducible COX-2 and mPGES-1 promoting cancer cell
proliferation in vitro and in vivo. Life Sci. 116:43–50. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kawahara K, Hohjoh H, Inazumi T, Tsuchiya
S and Sugimoto Y: Prostaglandin E2-induced inflammation: Relevance
of prostaglandin E receptors. Biochim Biophys Acta. 1851:414–421.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kosuge Y, Miyagishi H, Shinomiya T,
Nishiyama K, Suzuki S, Osada N, Ishige K, Okubo M, Kawaguchi M and
Ito Y: Characterization of motor neuron prostaglandin E2 EP3
receptor isoform in a mouse model of amyotrophic lateral sclerosis.
Biol Pharm Bull. 38:1964–1968. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
O'Callaghan G and Houston A: Prostaglandin
E2 and the EP receptors in malignancy: Possible therapeutic
targets? Br J Pharmacol. 172:5239–5250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nasrallah R, Hassouneh R, Zimpelmann J,
Karam AJ, Thibodeau JF, Burger D, Burns KD, Kennedy CR and Hébert
RL: Prostaglandin E2 increases proximal tubule fluid reabsorption,
and modulates cultured proximal tubule cell responses via EP1 and
EP4 receptors. Lab Invest. 95:1044–1055. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Säfholm J, Manson ML, Bood J, Delin I,
Orre AC, Bergman P, Al-Ameri M, Dahlén SE and Adner M:
Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction
in human small airways through the E prostanoid subtype 2 receptor.
J Allergy Clin Immunol. 136:1232–1239.e1. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mo C, Zhao R, Vallejo J, Igwe O, Bonewald
L, Wetmore L and Brotto M: Prostaglandin E2 promotes proliferation
of skeletal muscle myoblasts via EP4 receptor activation. Cell
Cycle. 14:1507–1516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
von der Emde L, Goltz D, Latz S, Müller
SC, Kristiansen G, Ellinger J and Syring I: Prostaglandin receptors
EP1-4 as a potential marker for clinical outcome in urothelial
bladder cancer. Am J Cancer Res. 4:952–962. 2014.PubMed/NCBI
|
|
34
|
Maślanka T, Spodniewska A, Barski D,
Jasiecka A, Zuśka-Prot M, Ziółkowski H, Markiewicz W and
Jaroszewski JJ: Prostaglandin E2 down-regulates the
expression of CD25 on bovine T cells, and this effect is mediated
through the EP4 receptor. Vet Immunol Immunopathol. 160:192–200.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kushima YM, Arai F, Hosokawa K, Toyama H,
Takubo K, Furuyashiki T, Narumiya S and Suda T: Prostaglandin E(2)
regulates murine hematopoietic stem/progenitor cells directly via
EP4 receptor and indirectly through mesenchymal progenitor cells.
Blood. 121:1995–2007. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoshida K, Oida H, Kobayashi T, Maruyama
T, Tanaka M, Katayama T, Yamaguchi K, Segi E, Tsuboyama T,
Matsushita M, et al: Stimulation of bone formation and prevention
of bone loss by prostaglandin E EP4 receptor activation. Proc Natl
Acad Sci USA. 99:4580–4585. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Singh P, Hoggatt J, Hu P, Speth JM, Fukuda
S, Breyer RM and Pelus LM: Blockade of prostaglandin E2 signaling
through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic
cell development from hematopoietic progenitor cells. Blood.
119:1671–1682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lapidot T, Dar A and Kollet O: How do stem
cells find their way home? Blood. 106:1901–1910. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Marquez-Curtis LA, Turner AR, Larratt LM,
Letcher B, Lee SF and Janowska-Wieczorek A: CD34+ cell
responsiveness to stromal cell-derived factor-1alpha underlies rate
of engraftment after peripheral blood stem cell transplantation.
Transfusion. 49:161–169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jung Y, Wang J, Schneider A, Sun YX,
Koh-Paige AJ, Osman NI, McCauley LK and Taichman RS: Regulation of
SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for
stem cell homing. Bone. 38:497–508. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Goessling W, North TE, Loewer S, Lord AM,
Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT
and Zon LI: Genetic interaction of PGE2 and Wnt signaling regulates
developmental specification of stem cells and regeneration. Cell.
136:1136–1147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Regan JW: EP2 and EP4 prostanoid receptor
signaling. Life Sci. 74:143–153. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang D, Mann JR and DuBois RN: WNT and
cyclooxygenase-2 cross-talk accelerates adenoma growth. Cell Cycle.
3:1512–1515. 2004. View Article : Google Scholar : PubMed/NCBI
|
